13 articles
Oral probiotics cut severe mouth sores during cancer treatment by 39%, with multi-strain formulas proving most effective, a review of 12 trials finds.
Brushing teeth twice daily cuts cavity risk in half, a Nigerian study finds, while poor oral hygiene raises cavity risk by 76%.
An AI system called XunZi analyzed 24 million studies to identify new Parkinson's disease targets, validating them in mouse models with promising results.
A liquid treatment called silver diamine fluoride stopped tooth decay in over half of baby teeth treated, with no drilling, no anesthesia, and no serious.
Cervical cancer is striking younger women at later stages, even as overall cases decline, revealing critical gaps in screening and prevention efforts.
Pig kidney transplants are nearing human trials, with experts tackling safety and longevity questions for the 100,000+ Americans awaiting a kidney.
Swiss researchers linked cancer drug approvals to real patient outcomes for the first time, revealing which treatments truly deliver survival benefits.
A minimally invasive knee osteoarthritis treatment called genicular artery embolization cut pain by 57% in patients who failed conventional therapies.
An NIH clinical trial found lifestyle changes beat medication for prediabetes, cutting risk of diabetes, heart disease, and kidney problems simultaneously.
Dupilumab shows promise for eosinophilic gastritis, while the FDA approves the first steroid-free topical psoriasis cream for children as young as 2.
NIH-funded medical research now costs scientists up to $12,850 per paper to publish openly, forcing researchers to choose between prestige journals and.
The FDA's Operation TrialBlazer is overhauling drug development rules, cutting delays of up to 12 months and replacing animal tests with AI-powered models.
Adaptive deep brain stimulation cuts freezing of gait in Parkinson's patients, but FDA approval hinges on validating the algorithm, not the hardware.
